Zobrazeno 1 - 10
of 52
pro vyhledávání: '"G Magenta"'
Autor:
Marcelo R. de Amorim, Daniel Rinaldo, Fabiano P. do Amaral, Wagner Vilegas, Mara A. G. Magenta, Gerardo M. Vieira Jr, Lourdes C. dos Santos
Publikováno v:
Química Nova, Vol 37, Iss 7, Pp 1122-1127 (2014)
This article describes the isolation and identification of flavonoids in the hydroethanolic extract of the aerial parts from Tonina fluviatilis and evaluation of their antiradical activity. A method based on HPLC-DAD was developed and validated for d
Externí odkaz:
https://doaj.org/article/b56d58e7e5e14c5db7a848aa40a9f89b
Autor:
E Piccinelli, A Maloberti, F Musca, L D’angelo, P Vallerio, R Pirola, N Morici, A Sacco, G Viola, G Magenta, F Oliva, M Lunati, A Moreo, C Giannattasio.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::f1dcc2beb353eacd20408f0b535226b8
http://hdl.handle.net/10281/262205
http://hdl.handle.net/10281/262205
Autor:
Massimo Mantica, P. Delise, G M De Ferrari, Roberto Mantovan, P. Turco, Mauro Gasparini, Renato Ometto, Michele Brignole, S Tognarin, F Pizzetti, Lorella Gianfranchi, Carlo Menozzi, G Magenta, F Acquati, Alessandro Proclemer
Publikováno v:
Heart. 82:494-498
OBJECTIVE—To assess the incidence of arterial embolic events in patients with high rate, drug resistant, severely symptomatic paroxysmal and chronic atrial fibrillation who have undergone atrioventricular (AV) node ablation and permanent pacing. DE
Autor:
G. Magenta, M. Lunati
Publikováno v:
Cardiac Arrhythmias 2005 ISBN: 8847003709
The Cardiac Resynchronization-Heart Failure (CARE-HF) trial [1] was a multicentre, international randomised trial whose aims were: 1. To assess the effect on morbidity and mortality of adding CRT to optimised pharmacological therapy in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28d66eb7ecf5e42a1741b2869d992deb
https://doi.org/10.1007/88-470-0371-7_65
https://doi.org/10.1007/88-470-0371-7_65
Publikováno v:
Cardiac Arrhythmias 2003 ISBN: 9788847021778
Sudden cardiac death (SCD) affects around 300,000–450,000 people annually in the USA, representing around 50% of all cardiac deaths. Patients with a medical history of ventricular tachycardia (VT) or ventricular fibrillation (VF) run a high risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::561024fb8d1a640c96202ce452a77996
https://doi.org/10.1007/978-88-470-2137-2_53
https://doi.org/10.1007/978-88-470-2137-2_53
Publikováno v:
Cardiac Arrhythmias 2003 ISBN: 9788847021778
Cardiac resynchronization therapy (CRT), a device-based therapy applied in the context of continuing conventional medical treatment for patients with advanced heart failure (HF) and dyssynchronous left-ventricular (LV) contraction, improves cardiac f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef1126ff71e720119446247560be9c4b
https://doi.org/10.1007/978-88-470-2137-2_114
https://doi.org/10.1007/978-88-470-2137-2_114
Publikováno v:
New Advances in Heart Failure and Atrial Fibrillation ISBN: 9788847021693
The creation of an interventional procedure effective in curing atrial fibrillation (AF) started with the surgical Maze procedure conceived and proposed by Cox in 1991 [1]. Electrophysiologists have tried since then to replicate the partitioning of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf3fb3d4f42c42e4c4ec49f2307094bf
https://doi.org/10.1007/978-88-470-2087-0_26
https://doi.org/10.1007/978-88-470-2087-0_26
Publikováno v:
Cardiac Arrhythmias 2001 ISBN: 9788847021655
Cardiac resynchronization therapy (CRT) with biventricular pacing has been recently explored as an adjunctive support to drugs to treat symptoms in patients with advanced heart failure (HF) (NYHA class III-IV), dilated cardiomyopathy (left ventricula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14312afdd3bb51c3578d8402861a7ecc
https://doi.org/10.1007/978-88-470-2103-7_28
https://doi.org/10.1007/978-88-470-2103-7_28
Autor:
G.B. Perego, Maria Frigerio, M. Garbellini, G. Cattafi, F. Oliva, Fabio Turazza, Andrea Garascia, Marco Paolucci, G. Magenta, M. Lunati, Ettore Vitali, I. Vicini
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20(2)
Publikováno v:
Cardiac Arrhythmias 1999-Vol.1 ISBN: 9788847000711
The permanent junctional reentry tachycardia (PJRT) is a rare form of reentrant supraventricular tachycardia (SVT), accounting for 1% of all SVTs, originally described by Coumel et al. in 1967 [1].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b03dbe268cf24225142989086a734130
https://doi.org/10.1007/978-88-470-2139-6_23
https://doi.org/10.1007/978-88-470-2139-6_23